Ocumension Therapeutics (HKG:1477)

Ocumension Therapeutics Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 16, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	6,654	6,034	3,670	4,614	6,757	11,668
Market Cap Growth	61.71%	64.39%	-20.44%	-31.72%	-42.09%	-26.90%
Enterprise Value	6,414	5,491	2,642	3,516	4,959	8,937
Last Close Price	8.16	7.40	4.50	6.68	9.81	17.50
Forward PE	177.86	265.99	-	-	-	-
PS Ratio	7.43	6.74	8.27	17.00	37.60	169.30
PB Ratio	1.62	1.47	0.91	1.43	2.17	3.06
P/TBV Ratio	5.54	5.02	2.58	2.35	3.27	3.96
EV/Sales Ratio	7.17	6.14	5.95	12.96	27.60	129.67
Debt / Equity Ratio	0.05	0.05	0.01	0.05	0.01	0.00
Net Debt / Equity Ratio	-0.06	-0.06	-0.20	-0.31	-0.47	-0.57
Net Debt / EBITDA Ratio	2.59	2.59	3.24	2.57	3.00	4.71
Net Debt / FCF Ratio	-	-	3.29	3.54	4.06	4.52
Asset Turnover	0.20	0.20	0.12	0.08	0.05	0.02
Inventory Turnover	8.10	8.10	4.93	3.61	3.85	4.79
Quick Ratio	2.89	2.89	6.02	3.72	5.76	8.48
Current Ratio	3.70	3.70	6.32	3.82	5.88	8.50
Return on Equity (ROE)	-4.26%	-4.26%	-8.02%	-13.40%	-13.75%	-9.27%
Return on Assets (ROA)	-2.48%	-2.48%	-5.29%	-7.96%	-8.94%	-8.13%
Return on Capital Employed (ROCE)	-4.20%	-4.20%	-8.00%	-13.60%	-16.30%	-12.40%
Earnings Yield	-2.66%	-2.93%	-7.78%	-9.07%	-6.74%	-2.73%
FCF Yield	-	-	-6.55%	-6.18%	-5.29%	-4.13%
Buyback Yield / Dilution	-16.13%	-16.13%	-5.33%	-2.63%	-4.18%	-100.81%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.